基本信息
浏览量:152
职业迁徙
个人简介
Research Interests
Preclinical study of natural products regulating programmed cell death
We mainly focuses on the preclinical development of naturals products that regulate programmed cell death (PCD). By using integrated platforms, we have identified naturals products with distinct mechanisms of action to induced PCD. We demonstrate that 2-methoxy-6-acetyl-7-methyljuglone (MAM), a type of quinone, induce cell-type dependent PCD dependent on ROS, caspase, RIPK1, or NQO1. We report for the first time that the form of PCD induced by MAM is distinct to any other types of PCD reported, and highly dependent on NQO1-mediated ROS production. We term this novel type of PCD as noptosis. We are still working on the underlying mechanisms and signaling that lead to noptosis. The therapetutic potential of noptosis is also being explored.
Development of epithelial-mesenchymal transition inhibitors
Epithelial-mesenchymal transition (EMT) is of pivotal importance in controlling tumor metastasis and organ fibrosis. By using the tumor growth factor β1-stimulated EMT model, we have identified a number of natural products as potent EMT inhibitors. Further study is on going to evaluate the therapeutic potential of these candidate EMT inhibitors on in vivo metasis and organ fibrosis models.Postgraduate students and masters who wish to participate in our research projects on pharmacology and drug discovery are all welcomed.
Preclinical study of natural products regulating programmed cell death
We mainly focuses on the preclinical development of naturals products that regulate programmed cell death (PCD). By using integrated platforms, we have identified naturals products with distinct mechanisms of action to induced PCD. We demonstrate that 2-methoxy-6-acetyl-7-methyljuglone (MAM), a type of quinone, induce cell-type dependent PCD dependent on ROS, caspase, RIPK1, or NQO1. We report for the first time that the form of PCD induced by MAM is distinct to any other types of PCD reported, and highly dependent on NQO1-mediated ROS production. We term this novel type of PCD as noptosis. We are still working on the underlying mechanisms and signaling that lead to noptosis. The therapetutic potential of noptosis is also being explored.
Development of epithelial-mesenchymal transition inhibitors
Epithelial-mesenchymal transition (EMT) is of pivotal importance in controlling tumor metastasis and organ fibrosis. By using the tumor growth factor β1-stimulated EMT model, we have identified a number of natural products as potent EMT inhibitors. Further study is on going to evaluate the therapeutic potential of these candidate EMT inhibitors on in vivo metasis and organ fibrosis models.Postgraduate students and masters who wish to participate in our research projects on pharmacology and drug discovery are all welcomed.
研究兴趣
论文共 366 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
MEDICINAL RESEARCH REVIEWS (2024)
International Journal of Drug Discovery and Pharmacology (2023)
引用0浏览0引用
0
0
Mu-Yang Huang,Yu-Chi Chen, Wen-Yu Lyu, Xin-Yu He,Zi-Han Ye,Can-Yu Huang,Xin-Ling He,Xiuping Chen,Xiaobing Chen, Baoxian Zhang,Guoyin Kai,Xiaolei Zhang,
AGRONOMY-BASELno. 9 (2023): 2415-2415
FRONTIERS IN PHARMACOLOGY (2023): 1288894-1288894
Materials Today Bio (2023): 100831-100831
DRUG RESISTANCE UPDATES (2023): 100977-100977
BRITISH JOURNAL OF PHARMACOLOGY (2023): 228-230
引用0浏览0引用
0
0
BRITISH JOURNAL OF PHARMACOLOGY (2023): 521-522
引用0浏览0引用
0
0
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn